US 7592322
RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof
granted A61KA61K2121/00A61P
Quick answer
US patent 7592322 (RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2121/00, A61P, A61P11/00, A61P31/14